Glucose-sensitive nanovaccine combines gene editing and immune activation for cancer treatment
| Date | 14th, Jul 2025 |
|---|---|
| Source | Nanowerk - Nanotechnology Websites |
DESCRIPTION
A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer.